Modern EDC streamlines key processes to
accelerate study builds and make mid-study amendments with no
downtime
PLEASANTON, Calif., June 6, 2024
/PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that
Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed") has selected
Veeva Vault EDC as its technology foundation for modern electronic
data capture (EDC). With Vault EDC, Tigermed can simplify complex
data management for faster study builds and mid-study amendments
with zero downtime. The improvements can significantly advance
Tigermed's clinical data management for the benefit of its
customers and the industry.
"We are delighted to partner with Veeva, advancing our
operations to help sponsors more efficiently manage clinical trials
and deliver on their commitments to the industry and patients
faster," said Ms. Gu Peili, vice president, head of data management
at Tigermed. "In recent years, rapid progress has been made in the
digitization of clinical trials and EDC in particular, as there
have been profound changes in the overseas markets. As a leading
CRO, Tigermed keeps investing in new technology, and adopting Veeva
Vault EDC will help us to consistently deliver the best experience
to our clients around the globe."
Tigermed is a leading provider of integrated research and
development solutions for the biopharmaceutical and medical device
industry. As EDC plays an important role in today's clinical
trials, Tigermed's adoption of Vault EDC will help manage the
increasing complexity of trials more efficiently while improving
data quality and study execution.
"We're proud to partner with Tigermed and drive faster, more
effective trials," said Juliana Lu,
senior director, R&D and quality and China country lead at Veeva. "With Veeva Vault
EDC, Tigermed can deliver more efficient data management services,
including higher data quality, lower costs, and a better user
experience for research sites. This can help accelerate the
development and launch of new drugs to improve patient health."
Veeva Vault EDC is part of the Veeva Clinical Platform, the most
complete and connected solution to meet the needs of patients,
sites, and sponsors. Eight of the top 20 biopharmas and two of the
top six global CROs have standardized on Vault EDC to manage future
clinical trials. To learn why more companies are adopting Vault
EDC, visit veeva.com/WhySwitchtoVaultEDC.
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva serves
more than 1,000 customers, ranging from the world's largest
biopharmaceutical companies to emerging biotechs. As a Public
Benefit Corporation, Veeva is committed to balancing the interests
of all stakeholders, including customers, employees, shareholders,
and the industries it serves. For more information, visit
veeva.com.
Veeva Forward-looking Statements
This release
contains forward-looking statements regarding Veeva's products and
services and the expected results or benefits from use of our
products and services. These statements are based on our current
expectations. Actual results could differ materially from those
provided in this release and we have no obligation to update such
statements. There are numerous risks that have the potential to
negatively impact our results, including the risks and
uncertainties disclosed in our filing on Form 10-Q for the period
ended April 30, 2024, which you can
find here (a summary of risks
which may impact our business can be found on pages 35 and 36), and
in our subsequent SEC filings, which you can access
at sec.gov.
Contact:
Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/tigermed-advances-clinical-data-management-with-veeva-vault-edc-302164013.html
SOURCE Veeva Systems